Aprea Therapeutics, Inc.

Historical 13F Holders

Symbol
APRE
CUSIP
03836J201
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03836J201 since 12/18/2024, largest first.

Filer % of Class Filed
Vestal Point Capital, LP 13G
9.9% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Nantahala Capital Management, LLC 13G/A
4.5% 2/13/2026
Event 12/31/2025
Stonepine Capital Management, LLC 13G/A
4.3% 5/14/2025
Event 3/31/2025
Lytton Laurence W 13G/A 3.2% 8/13/2026
Event 6/30/2026
Sio Capital Management, LLC 13G/A 1.9% 11/12/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 28 3.35 M $2.51M
2026 Q2 27 2.37 M $1.90M
2026 Q1 22 2.24 M $1.71M
2025 Q4 22 1.70 M $1.45M
2025 Q3 23 1.62 M $2.39M
2025 Q2 24 1.82 M $3.07M
2025 Q1 27 1.95 M $3.78M
2024 Q4 27 2.08 M $6.83M
2024 Q3 22 2.00 M $5.50M
2024 Q2 28 2.08 M $8.48M
2024 Q1 23 1.62 M $10.8M
2023 Q4 21 927 k $4.36M
2023 Q3 22 877 k $3.66M
2023 Q2 20 882 k $2.78M
2023 Q1 17 848 k $3.77M